Law
Thai FDA Clarifies Classification of High-Fluoride Toothpaste
The Thai Food and Drug Administration has addressed public concerns following a new regulation classifying toothpaste containing 5,000 ppm fluoride as a 'dangerous drug'.
On August 6, 2026, the Thai Ministry of Public Health issued a notification designating oral products containing 5,000 parts per million (ppm) of fluoride as 'dangerous drugs'. This announcement, published in the Royal Gazette, has prompted questions and concerns among consumers regarding the safety and accessibility of these products.
According to Prachachat Business, the Thai Food and Drug Administration (FDA) has stepped in to clarify the classification. The designation as a 'dangerous drug' does not necessarily imply that the product is toxic, but rather that it requires specific oversight and professional guidance for its use. This regulatory change is intended to ensure that high-concentration fluoride products are used appropriately, likely under the recommendation of dental professionals, rather than being treated as standard over-the-counter consumer goods.
For residents and long-term visitors in Thailand, this means that toothpaste with this specific fluoride concentration may no longer be available for casual purchase in general retail stores. It is important to note that this regulation specifically targets the 5,000 ppm concentration level.
What remains to be confirmed is the specific distribution channel that will be authorized for these products moving forward and whether pharmacies will require a prescription or professional consultation to dispense them. Individuals currently using high-fluoride toothpaste are advised to consult with their local dentist to determine if their specific product is affected by this new legal status and to discuss appropriate alternatives if necessary.